Opportunistic infections resulting from late HIV diagnosis: Case report
DOI:
https://doi.org/10.33448/rsd-v12i5.41465Keywords:
HIV seroprevalence; HIV infections; Opportunistic diseases.Abstract
Opportunistic infections represent a serious public health problem, especially in patients with immunodeficiency caused by HIV. If not treated properly, these infections can be serious and even fatal. The objective of this study is to report the case of a patient with a late diagnosis of HIV, who presented opportunistic infections. This is a clinical report of a 36-year-old bisexual man who was admitted to the hospital with symptoms of anorexia, rectal pain, abdominal pain and severe anemia. During his admission, it was discovered that he was infected with HIV and also had opportunistic infections, including esophageal candidiasis, HPV and CMV. After receiving a series of therapies, the patient showed significant improvement, with resolution of the initial symptoms and control of opportunistic infections, so he was referred for follow-up on an outpatient basis. Although the patient showed improvements in his condition, it is crucial to emphasize that his participation in the study revealed irreversible damage in terms of prevention. For years, he inadvertently transmitted the HIV virus, putting a significant number of people at risk. This highlights the critical challenge that delay in HIV diagnosis poses to controlling the epidemic.
References
Alsomali, M. I., Arnold, M. A., Frankel, W. L., Graham, R. P., Hart, P. A., Lam-Himlin, D. M., Naini, B. V., Voltaggio, L., Arnold, C. A. (2017). Challenges to "Classic" Esophageal Candidiasis: Looks Are Usually Deceiving. Am J Clin Pathol, v.147(1):33-42, 2017. DOI: 10.1093/ajcp/aqw210
Alves, S. M., Cardoso, G., Romão, N. F. (2019). Candidíase esofágica: uma revisão de literatura. Brazilian Journal of Surgery and Clinical Research – BJSCR, 27(1), 136-146, 2019. https://www.mastereditora.com.br/periodico/20190607_200528.pdf
Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 20;220(4599):868-71, 1983. DOI: 10.1126/science.6189183.
Beltrán, C., Zitko, P., Wolff, M., Bernal, F., Asenjo, A., Fernández, A. M., Miles, A., Barthel, E., Wilson, G. (2016). Evolución de las características epidemiológicas y clínicas de pacientes adultos del programa nacional al início de la terapia anti-retroviral en la Cohorte Chilena de SIDA, 2001-2015. Rev Chil Infectol, 33(1):2-10, 2016. DOI: http://dx.doi.org/10.4067/S0716-10182016000700001
Bieniek, R., Kirby, J. E., Cheng, A., Eichelberger, K., Qian, Q. (2011). Effective use of PCR for the detection of cytomegalovirus viremia and monitoring therapy in immunocompromised patients. Laboratory medicine, v. 42(6):339–43, 2011. DOI: https://doi.org/10.1309/LMP4IL3XGU6MQJCE
Brasil. Ministério da Saúde. (2020). Casos de Aids diminuem no Brasil. https://www.gov.br/aids/pt-br/assuntos/noticias-periodo-eleitoral/casos-de-aids-diminuem-no-brasil#:~:text=Atualmente%2C%20cerca%20de%20920%20mil,terem%20atingido%20carga%20viral%20indetect%C3%A1vel.
BRASIL. Ministério da Saúde. (2020). Secretaria de Vigilância em Saúde. Boletim Epidemiológico: HIV/Aids | 2020. Brasília, 2020. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2020/boletim-hiv_aids-2020-internet.pdf
Brasil. Ministério da Saúde. (2021). Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Boletim Epidemiológico HIV/Aids 2021. Disponível em: https://www.gov.br/saude/pt-br/media/pdf/2021/dezembro/01/boletim_epidemiologico_hiv_aids_2021_pdf_.pdf. Acesso em: 20 mar. 2023.
Camoni, L., Raimondo, M., Regine, V., Salfa, M., Suligoi, B., Regional representatives of the HIV Surveillance System. (2013). Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011. BMC Public Health, v. 13(281): 3-6, 2013. DOI: https://doi.org/10.1186/1471-2458-13-281
Centers for Disease Control and Prevention (CDC). (2023). HIV and Gay and Bisexual Men. Disponível em: https://www.cdc.gov/hiv/group/msm/index.html. Acesso em: 20 mar. 2023.
Centros de Controle e Prevenção de Doenças (CDC). (2019). AIDS e infecções oportunistas, 2019. https://www.cdc.gov/hiv/basics/livingwithhiv/opportunisticinfections.html. Acesso em: 20 mar. 2023
Christensen-Quick, A., Massanella, M., Frick, A., Rawlings, S. A., Spina, C., Vargas-Meneses, M., Schrier, R., Nakazawa, M., Anderson, C., Gianella, S. (2019). Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy. J. Virol, v. 93(13): e00179-19, 2019. DOI: 10.1128/JVI.00179-19
Colaço, A. D., Meirelles, B. H. S., Heidemann, I. T. S. B., Villarinho, M. V. (2019). O cuidado à pessoa que vive com HIV/AIDS na atenção primária à saúde. Texto contexto - enferm. 28, 1-14, 2019. DOI: https://doi.org/10.1590/1980-265X-TCE-2017-0339
Durier, N., Ananworanich, J., Apornpong, T., Ubolyam, S., Kerr, S.J., Mahanontharit, A., Ferradini, L., Ruxrungtham, K., Avihingsanon, A. (2013). Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality. Clin Infect Dis., v.57(1):147-55, 2013. DOI: 10.1093/cid/cit173.
Ethiopian Public Health Institute (EPHI). (2018). Ethiopia Population-Based HIV Impact Assessment (EPHIA) 2017–2018. Summary Sheet: Preliminary Findings; April, 2018:4–7. https://phia.icap.columbia.edu/wp-content/uploads/2018/12/3511%E2%80%A2EPHIA-Summary-Sheet_v30.pdf
Ethiopian Public Health Institute. (EPHI). (2017). HIV related estimates and projections for Ethiopia - 2017. Ethiopian Public Health Institute; March, 2017. http://repository.iifphc.org/handle/123456789/465
Federal HIV/AIDS Prevention and Control Office (FHAPCO). (2018). HIV prevention in Ethiopia: National Road Map – 2018-2021; 1–4, 2018. https://ethiopia.unfpa.org/sites/default/files/pub-pdf/HIV%20Prevention%20in%20Ethiopia%20National%20Road%20Map%202018%20-%202020%20FINAL_FINAL.pdf
Fernandez, M. M., Lievano, J. F. R., Vidal, R. P., Perez, A. F., Reula, A. T., & Masferrer, J. M. (2020). Prevalence of late diagnosis of HIV infection. Medicina Clinica (English Ed.), 55(9), 388– 391. DOI: https://doi.org/10.1016/j.medcle.2020.01.012
Ford, N., Shubber, Z., Meintjes, G., Grinsztejn, B., Eholie, S., Mills, E.J., et al. (2015). Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV, v.2(10):e438–444, 2015. DOI: 10.1016/S2352-3018(15)00137-X
Gamboa, B., Zambrano, R.E., Lizzetti, G., Soto, A., Lucchetti, A. (2018). Factores asociados a sobrevida en pacientes con co-infección VIH-TBC en el Servicio de Infectología del Hospital Nacional Arzobispo Loayza, Perú, durante los años 2004-2012. Rev Chil Infectol, v.35:41-8, 2018. DOI: http://dx.doi.org/10.4067/s0716-10182018000100041
Gentil, F. A., Dias, D. T., Pacheco, D. F., Luz, E. A., Costa, L. G. F. S., Brum, R. M. O. (2016). Criptococose: relato de caso. Acta Biomedica Brasiliensia, 7(2), 102-109, 2016. DOI: http://dx.doi.org/10.18571/acbm.114
Ghiasvand, H., Waye, K.M., Noroozi, M., Harouni, G.G., Armoon, B., Bayani, A. (2019). Clinical determinants associated with quality of life for people who live with HIV/AIDS: A meta-analysis. BMC Health Services Research, v.19(1):768, 2019. DOI: 10.1186/s12913-019-4659-z
Gianella, S., Massanella, M., Wertheim, J.O., Smith, D.M. (2015). The sordid case between human herpesvirus and HIV. J Infect Dis., v. 212:845–852, 2015. DOI: 10.1093/infdis/jiv148
Group, T. I. S. S. (2017). Early treatment in asymptomatic HIV infection. Physiol Behav, v.176(1): 139–148, 2017. DOI: 10.1056/NEJMoa1506816.Initiation
Instituto de Saúde Pública da Etiópia (EPHI). (2018). Ethiopia population-based hiv impact assessment Ephia 2017-2018. Summary Sheet: Preliminary Results; Abril de 2018: 4–7. Https://phia.icap.columbia.edu/wp-content/uploads/2018/12/3511%E2%80%A2EPHIA-Summary-Sheet_v30.pdf
Iroezindu, M. (2016). Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend? Ann Med Health Sci Res., v.6 (1):4, 2016. DOI: 10.4103/2141-9248.180234
Jordan, R. E., Adab, P., Cheng, K. K. (2020). Covid-19: risk factors for severe disease and death. BMJ, 368, 1-2, 2020. DOI: https://doi.org/10.1136/bmj.m1198
Joshi, R.K., Mehendale, S.M. (2019). Determinants of consistently high HIV prevalence in Indian Districts: A multi-level analysis. PLoS One., v.14 :e0216321, 2019. DOI: 10.1371/journal.pone.0216321.
Kasper, F. (2015). Harrison’s Principles of Internal Medicine. 19th ed. New York: The McGraw-Hill Companies, Inc.; 2015.
Koethe, J. R., & Heimburger, D. C. (2010). "Nutritional aspects of HIV-associated wasting in sub-Saharan Africa". The American journal of clinical nutrition, 91(4), 1138S-1142S. DOI: https://doi.org/10.3945/ajcn.2010.28608D
Likatavicius, G., Van de Laar, M. (2012). HIV and AIDS in the European Union, 2011. Eurosurveillance. 2012;17(48):20329. DOI: https://doi.org/10.2807/ese.17.48.20329-en
Lima, R. A., da Silva, M. R., & da Silva, M. T. (2016). Manifestações orais em pacientes com HIV/AIDS: revisão de literatura. Revista de Odontologia da UNESP, 45(1), 11-16. DOI: http://dx.doi.org/10.33448/rsd-v11i14.30859
Liu, X., Lin, H., Chen, X., Shen, W., Ye, X., Lin, Y., Lin, Z., Zhou, S., Gao, M., Ding, Y., He, N. (2019). Prevalence and genotypes of anal human papillomavirus infection among HIV-positive vs. HIV-negative men in Taizhou, China. Epidemiol Infect., v.147:e117, 2019. DOI: 10.1017/S0950268818003205.
Low, A., Gavriilidis, G., Larke, N, MR, B.L., Drouin, O., Stover, J., et al. (2016). Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Clin Infect Dis., v. 62(12):1595–1603, 2016. DOI: 10.1093/cid/ciw125
Markwick, N. , Ti, L. , Callon, C. , Feng, C. , Wood, E. , & Kerr, T. (2014). Disposição para se envolver em aconselhamento e testagem voluntária de HIV entre pessoas que usam drogas injetáveis em um ambiente canadense . Revista de Epidemiologia e Saúde Comunitária, v.68, 675 – 678, 2014. DOI: https://doi.org/10.1136/jech-2013-203707
May, M. T. (2017). Better to know: the importance of early HIV diagnosis. Lancet Public Heal 2017; 2(1): e6–e7. DOI: 10.1016/S2468-2667(16)30038-X.
Melo, M.C., Mesquita, F.C., Barros, M.B.A., La-Rotta, E.I.G., Donalisio, M.R. (2019). Sobrevida de pacientes com aids e associação com escolaridade e raça/cor da pele no Sul e Sudeste do Brasil: estudo de coorte, 1998-1999. Epidemiol Serv Saúde, v.28:1998-9, 2019. DOI: https://doi.org/10.5123/S1679-49742019000100012
Morris, S.R., Zhao, M., Smith, D.R., Vargas, M.V., Little, S.J., Gianella, S. (2016). Longitudinal viral dynamics in semen during early HIV infection. Clin Infect Dis, v.64:428–434, 2016. DOI: https://doi.org/10.1093/cid/ciw784
Mulisa, D., Tesfa, M., Mullu Kassa, G., Tolossa, T. (2019). Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: Un-matched case control study. BMC Infectious Diseases, v.19(1):1024, 2019. DOI: 10.1186/s12879-019-4651-6
Murray, J., Hilbig, A., Soe, T.T. et al. (2020). Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data. BMC Infect Dis, v.20, 842, 2020. DOI: https://doi.org/10.1186/s12879-020-05579-2
O'Byrne, P. , & Orser, L. (2019). Teste expresso para infecções sexualmente transmissíveis: resultados clínicos. Revista de Pesquisa em Enfermagem, v. 24 (7), 541 – 547, 2019. DOI: https://doi.org/10.1177/1744987119843152
O'Byrne, P., & Orser, L. (2020). Avoiding missed opportunities to screen for HIV. Journal of the American Association of Nurse Practitioners, v.32(5), 408– 414, 2020. DOI: https://doi.org/10.1097/JXX.0000000000000274
Organização Mundial da Saúde (OMS). (2015). Diretrizes Diretrizes sobre Quando Iniciar Terapia Antirretroviral e Profilaxia Pré-Exposição para HIV . World Heal Organ [Internet]; 2015, setembro:78 Disponível em: http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
Organização Mundial da Saúde (OMS). (2016). Global health sector strategy on HIV 2016-2021. Towards ending AIDS. World Health Organization. https://apps.who.int/iris/handle/10665/246178
Palefsky J. (2009). Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS. 2009 Jan;4(1):52-6. DOI: 10.1097/COH.0b013e32831a7246. PMID: 19339939; PMCID: PMC2756707.
Pappas P.G., Kauffman C.A., Andes D.R., et al, (2016). Diretriz de prática clínica para o manejo da candidíase: atualização de 2016 pela Sociedade de Doenças Infecciosas da América. Clin Infect Dis, v. 62(4):e1–e50, 2016. DOI: 10.1093/cid/civ933
Poorolajal, J., Hooshmand, E., Mahjub, H., Esmailnasab, N., & Jenabi, E. (2016). Survival rate of AIDS disease and mortality in HIV-infected patients: A meta-analysis. Public Health, v.139, 3– 12, 2016. DOI: https://doi.org/10.1016/j.puhe.2016.05.004
Public Health Agency of Canada [PHAC]. (2016). Canadian Guidelines on sexually transmitted infections: HIV infections, 2016. https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/sexually-transmitted-infections/canadian-guidelines-sexually-transmitted-infections-36.html
Revankar, S. G. (04/2021). Candidiasis (Invasive). Merck Manual Professional Version, abr. de 2021. https://www.merckmanuals.com/professional/infectious-diseases/fungi/candidiasis-invasive?query=Esophageal%20Candidiasis.
Robertson, K.D., Nagra, N., Mehta, D. (2023). Esophageal Candidiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK537268/
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Raben, D., Coll, P., Antinori, A., Nwokolo, N., Rieger, A., Prins, J. M., Blaxhult, A., Weber, R., Eeden, A. V., Brockmeyer, N. H. ... Lundgren, J. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet, 393, 2428– 2438, 2019. DOI: 10.1016/S0140-6736(19)30418-0
Rosołowski M, Kierzkiewicz M. (2013). Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol, v. 8(6):333-7, 2013. DOI: 10.5114/pg.2013.39914
Siedner, M. J., Triant, V. (2019). Undetectable = untransmittable and your health: the personal benefits of early and continuous therapy for HIV infection. J Infect Dis. 219, 173– 176, 2019. DOI: doi: 10.1093/infdis/jiy445.
Souza, C. N. de, Costa, O. L. B., Sanches, F. L. F. Z., & Guimarães, R. de C. A. (2018). Perfil nutricional de pacientes HIV/Aids hospitalizados. Multitemas, v. 23(53), 159–181. DOI: https://doi.org/10.20435/multi.v23i53.1566
Tenorio, C. H., Ramírez-Taboada, J., Gil-Anguita, C., Esquivias, J., Omar-Mohamed-Balgahata, M., SamPedro, A., Lopez-Ruz, M., Pasquau, J. (2017). Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM). AIDS Res Ther., v.18;14(1):34, 2017. DOI: 10.1186/s12981-017-0160-0.
Tewachew, A. S., Mekonnen, W. N., Mekuria, A. D., Amare, Y. E. (2021). Determinants of Opportunistic Infections Among HIV-Positive Patients on HAART in Debre Berhan Referral Hospital, North Shoa Zone, Ethiopia, 2020: A Case–Control Study. HIV AIDS (Auckl), 13: 337–347, 2021. DOI: 10.2147/HIV.S298661
Trickey, A., May, M., Vehreschild, J., Obel, N., Gill, M.J. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV, v.4:349-56, 2017. DOI: 10.1016/S2352-3018(17)30066-8
Unaids (Brasil). (2022). Estatísticas Globais do HIV, 2022. https://unaids.org.br/wp-content/uploads/2022/07/2022_07_27_Factsheet_PT.pdf
Urgessa, F., Ararsa, A., Ataro, Z. (2018). Prevalence and associated risk factors of opportunistic infections among anti-retro viral treatment naive HIV/AIDS infected patients. J AIDS Clin Res., v.09(03), 2018. DOI: 10.4172/2155-6113.1000763
Weissberg, D., Mubiru, F., Kambugu, A., Fehr, J., Kiragga, A., Von Braun, A., et al. (2018). Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort. PLoS One, v.13(11):e0206796, 2018. DOI: 10.1371/journal.pone.0206796
World Health Organization (WHO). (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016. Disponível em: https://www.who.int/publications/i/item/9789241549684. Acesso em: 20 mar. 2023.
Zhao, M., Zhuo, C., Li, Q., Liu, L. (2020). Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types. Annals of Palliative Medicine, v.9(5):2710-2715, 2020. DOI: 10.21037/apm-20-1352.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 José de Almeida Alexandre; Thalisson Max de Oliveira Lopes; José Ledesvan Pereira dos Santos Junior; Eloisa Simões Alves ; Letícia Maria Cavalcanti Brito ; Júlia Carla Oliveira Silva ; Fernanda Lopes de Oliveira; Isabela Simões Alves; Jéssica Laís da Silva ; Bernadete Barros Ceryno
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
